# CD19-CART Treatment for ALL

> **NCT03232619** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bioray Laboratories** · enrollment: 4 (actual)

## Conditions studied

- Acute Leukemia

## Interventions

- **BIOLOGICAL:** CD19 CART

## Key facts

- **NCT ID:** NCT03232619
- **Lead sponsor:** Bioray Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2020-05-06
- **Final completion:** 2020-09-15
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03232619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03232619, "CD19-CART Treatment for ALL". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03232619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*